Skip to main content
. 2002 Aug 21;89(2):97–114. doi: 10.1016/S0378-1135(02)00174-8

Table 2.

Results of PCV2 isolation by two passages on PK-15 cells and determination of the PCV2 infectious titer in 10% (w/v) tissue homogenates from control and experimentally PCV2-infected pigs

Experimental group Pig no. PIDb Pool 1c PCV2 (log10 TCID50/g)a
Pool 2 Pool 3 Pool 4

PCV2 11d 21 +e (4.9f) + (4.7) + (5.3) + (3.7)
12d 21 + (5.7) + (6.1) + (5.5) + (4.7)
13d 25 + (4.5) + (5.7) + (5.5) + (3.9)
14 36 + (<1.5) + (<1.5) + (<1.5) + (<1.5)
15 36 + (<1.5) + (<1.5) + (<1.5) + (<1.5)


PCV2+immunisation 

16 

36 

+ (<1.5) 

+ (<1.5) 

+ (<1.5) 

+ (<1.5)
17 36 + (<1.5) + (<1.5) + (<1.5) + (<1.5)
18d 22 + (5.3) + (5.9) + (4.9) + (2.7)
19 36 + (<1.5) + (<1.5) + (<1.5) + (<1.5)
20 36 + (<1.5) + (<1.5) + (<1.5) + (<1.5)
a

log10TCID50/g=50% tissue culture infectious dose per gram of tissue.

b

Postinoculation day.

c

Pool 1: tissue homogenate of inguinal and prescapular lymph nodes; pool 2: tissue homogenate of spleen, mesenteric and bronchial lymph nodes; pool 3: tissue homogenate of lung, liver, and kidney; pool 4: tissue homogenate of tonsils.

d

Pig that died or was euthanized before termination of the experiment on PID 36.

e

Plus (+) denotes isolation of PCV2.

f

The infectious titer of PCV2.